The University of Chicago Header Logo

Connection

Luciana Molinero to Programmed Cell Death 1 Receptor

This is a "connection" page, showing publications Luciana Molinero has written about Programmed Cell Death 1 Receptor.
  1. Safety, clinical activity and biomarker assessments of atezolizumab from a Phase I study in advanced/recurrent ovarian and uterine cancers. Gynecol Oncol. 2019 08; 154(2):314-322.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.